Updated MoH Guidelines – Booster Shots for Immunocompromised Patients After Primary Series
On December 14, 2021, the Ministry of Health published updated guidelines on COVID-19 Vaccine Third Dose Recommendations.Highlights of changes:•Immunocompromised individuals who are eligible for a three-dose primary series may receive a booster dose ≥6 months […]
CMAJ Article: Projected impact of biosimilar substitution policies on drug use and costs in Ontario
The full article may be viewed via this link: https://www.cmajopen.ca/content/9/4/E1055 […]
Long COVID Study – Brain and Cognition Discovery Foundation
The Brain and Cognition Discovery Foundation has announced an ongoing clinical study that may be of interest to patients you provide care for who are experiencing complications from COVID-19. More information is available […]
Ontario Rheumatologists Warn: Immunocompromised Patients are Being Put at Risk for COVID-19
The ORA has issued a press release in order to increase awareness and understanding of the new Ministry guidelines on accessing 3rd doses of the COVID-19 Vaccine. The press release is available via […]
Geoff Carr Lupus Fellowship 2022/2023 – Now Accepting Applications!
Members of Lupus Ontario established a Fellowship in memory of their colleague, the late Geoff Carr. The annual Fellowship is designed to provide advanced training to a rheumatologist specializing in lupus at an […]
Verified Virtual Visit Solutions for Providers
To assist health service providers in the selection of virtual care solutions appropriate for clinical use, Ontario Health has established a provincial standard (The Standard) and launched a verification process for virtual care […]
JointHealth™ express – ACE National Survey on Arthritis Self-Advocacy (For Patients)
Arthritis Consumer Experts (ACE) is conducting a National Survey on Self-Advocacy. Please support this initiative by sharing with your patients. The link below offers more information, including the survey link: Self Advocacy Survey […]
Updated Biosimilar Fact Sheet
June 24 Biosimilar-Fact-Sheet […]
Updated Recommendations From the Vaccine Clinical Advisory Group
The Vaccine Clinical Advisory Group has published updated Recommendations on Exceptions to Extended Dose Intervals for COVID-19 vaccines. Please note that this is not yet government policy. To review the entire report, click […]
New Feature on SADIE: The Exceptional Access Program Digital Assistant – Now With Delegates!
The Ministry of Health continues to modernize the Exceptional Access Program (EAP) and transition away from fax-based processes by December 31, 2021. As the next major step forward, you can now assign delegates in SADIE who can create and […]
